Biomarin Pharmaceutical Inc (USD)
BMRN
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range88.91 | 90.00
52-Wk Range62.88 | 96.20
Last Close88.94
Mkt Cap (m)15,975.87
Dividend yield-
ISINUS09061G1013
Volume647,613
Exchange VenueNAS

Company Profile

Biomarin Pharmaceutical Inc is on rare-disease therapies. It develops and commercializes pharmaceuticals for serious diseases and medical conditions.

Key Information
Price/Earning-
Price/Book5.20
Price/Sales9.92
P/CF394.78
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 09/08/2017
Annual Report
en 31/12/2018

Financials

Income Statement
USD201420152016201720182019
Revenue (m)7518901,1171,3141,491-
Operating Income (m)-160-282-204-140-174-
Net Income (m)-134-172-630-117-77-
Basic EPS-0.92-1.07-3.80-0.67-0.44-
Avg. Diluted Shares Outstanding (m)146160166174177-
Balance Sheet
USD201420152016201720182019
Current Assets (m)1,4261,0901,4222,2072,056-
Non Current Assets (m)1,0652,6402,6022,4262,371-
Total Assets (m)2,4903,7294,0244,6334,427-
Current Liabilities (m)236445439817523-
Total Liabilities (m)------
Total Equity (m)1,5282,4012,7662,8092,968-
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-74-222-228-920-
Capital Expenditure (m)-119-228-148-199-145-
Figures are quoted in USD unless stated otherwise
0.93 (1.05%)
$
89.87
Last Price